LifeSprout is developing revolutionary synthetic soft tissues for aesthetic and reconstructive medicine. Leveraging recent breakthroughs in materials science, we have created a platform that looks and behaves like the body’s own tissues. We are turning this into a suite of products for the millions of patients each year with soft tissue losses from aging, cancer, and metabolic disease. Our next generation products enhance form and function with minimal downtime and superb results.
We are developing best-in-class solutions to the challenges of soft tissue restoration. We aim for all patients to be whole. To be healthy. To be their best selves.
We are a team of passionate scientists, clinicians, and entrepreneurs. We are driven by integrity, excellence, creativity, tenacity, and joy.
LifeSprout completes GMP production of first injectable products
LifeSprout clarifies PMA pathway in pre-IDE meeting with FDA
LifeSprout closes Series Seed Financing with major venture capital and strategic leads ($6,500,000)
LifeSprout wins Johnson & Johnson QuickFire Device Challenge and AngelMD Sponsorship ($275,000)
LifeSprout wins Maryland Stem Cell Research and Commercialization Fund Award ($300,000)
Exclusive license secured to foundational intellectual property from Johns Hopkins University
Team receives major sponsored research award from the Abell Foundational ($660,000)
Team wins translational grant funding from Johns Hopkins and the State of Maryland ($305,000)